rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
30
|
pubmed:dateCreated |
2006-7-24
|
pubmed:abstractText |
Peptide aptamers (PAs) can be employed to block the intracellular function of target proteins. Little is known about the mechanism of PA-mediated protein inhibition. Here, we generated PAs that specifically bound to the duck hepatitis B virus (HBV) core protein. Among them, PA34 strongly blocked duck HBV replication by inhibiting viral capsid formation. We found that PA34 led to a dramatic intracellular redistribution of its target protein into perinuclear inclusion bodies, which exhibit the typical characteristics of aggresomes. As a result, the core protein is efficiently removed from the viral life cycle. Corresponding findings were obtained for bioactive PAs that bind to the HBV core protein or to the human papillomavirus-16 (HPV16) E6 protein, respectively. The observation that PAs induce the specific sequestration of bound proteins into aggresomes defines a novel mechanism as to how this new class of intracellular inhibitors blocks the function of their target proteins.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Aptamers, Peptide,
http://linkedlifedata.com/resource/pubmed/chemical/E6 protein, Human papillomavirus...,
http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Proteins, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Repressor Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Vimentin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0021-9258
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
28
|
pubmed:volume |
281
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
21345-52
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16717089-Amino Acid Sequence,
pubmed-meshheading:16717089-Antiviral Agents,
pubmed-meshheading:16717089-Aptamers, Peptide,
pubmed-meshheading:16717089-Cell Line, Tumor,
pubmed-meshheading:16717089-Hepatitis B virus,
pubmed-meshheading:16717089-Humans,
pubmed-meshheading:16717089-Molecular Sequence Data,
pubmed-meshheading:16717089-Oncogene Proteins, Viral,
pubmed-meshheading:16717089-Peptides,
pubmed-meshheading:16717089-Plasmids,
pubmed-meshheading:16717089-Protein Binding,
pubmed-meshheading:16717089-Proteins,
pubmed-meshheading:16717089-Repressor Proteins,
pubmed-meshheading:16717089-Vimentin,
pubmed-meshheading:16717089-Virus Replication
|
pubmed:year |
2006
|
pubmed:articleTitle |
Peptide aptamer-mediated inhibition of target proteins by sequestration into aggresomes.
|
pubmed:affiliation |
Molecular Therapy of Virus-Associated Cancers Group (F065), German Cancer Research Center, Heidelberg.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|